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Abstract
In mammals milk is the principal nutrient for neonates at birth. The basic milk composition 
is similar between different mammals, but the content of individual constituents such as lipids 
may differ significantly from one species to another. The milk fat fraction is mainly composed of 
triglycerides which account for more than 95% of the lipids found in human and bovine milk. 
Though sterols and in particular cholesterol, the predominant milk sterol, represent less than 
0.5% of the total milk lipid fraction, they are of ultimate importance for biological processes 
such as the formation of biological membranes or as precursors for steroid hormone synthesis. 
Cholesterol found in milk originates either from blood uptake or from local synthesis. This 
chapter provides an overview of cholesterol exchanges between the blood, the mammary tissue 
and the milk. The current knowledge on the expression, localization and function of candidate 
cholesterol transporters in mammary tissues of human, murine and bovine origin is summarized. 
Different mechanisms of how cholesterol can be transferred via the mammary tissue into milk, 
and which active cholesterol transporters are likely to play a role in this process will be discussed.
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Key facts
•	Cholesterol	 is	a	crucial	molecule	which,	as	a	cell	membrane	constituent,	 is	essential	 for	cell	growth	and	
renewal	as	well	as	for	the	synthesis	of	specific	hormones.
•	Milk	and	its	derived	products	are	one	of	the	most	important	sources	of	cholesterol	in	the	human	diet	(both	
adults	and	infants).	Regarding	its	role	as	a	nutrient	found	in	milk	considerable	and	often	controversial	effects	
of	cholesterol	on	human	health	are	discussed.	In	this	context	 it	seems	important	 to	distinguish	cholesterol	
effects	in	babies/infants	as	opposed	to	adults.
•	Babies	consume	very	high	amounts	of	cholesterol	per	kg	of	body	weight	compared	to	adults	without	showing	
detrimental	effects	attributed	to	high	cholesterol	intake.	Interestingly,	the	increase	of	serum	cholesterol	levels	
in	breastfed	babies	is	more	pronounced	as	compared	to	milk	formula	fed	babies.
•	The	identification	of	active	cholesterol	transporters	in	other	peripheral	tissues	have	revolutionized	the	current	
thinking	of	how	cholesterol	is	transported	or	exported	from	epithelial	cells.	Therefore,	the	current	concept	of	
cholesterol	trafficking	in	the	mammary	gland	needs	re-thinking	and	the	role	of	active	cholesterol	transporters	
in	this	process	has	to	be	elucidated.
Summary points
•	Cholesterol	is	the	predominant	sterol	found	in	milk.	It	enters	the	latter	from	the	blood	where	it	circulates	bound	
to	various	carrier	proteins	such	as	very	low	density	 lipoprotein,	 low	density	 lipoprotein,	and	high	density	
lipoprotein.
•	The	transcellular	transport	of	cholesterol	in	the	mammary	gland	implies	an	uptake	from	the	blood	circulation,	
redistribution	in	cytosolic	compartments	and	release	into	milk.
•	The	cholesterol	transport	into	milk	involves	energy-dependent	and	energy-independent	processes	that	operate	
at	the	basal	side	of	the	blood-milk	barrier	(facing	the	blood,	cholesterol	uptake)	and	at	the	opposite	apical	
side	(facing	the	milk,	cholesterol	release).
•	The	transport	of	cholesterol	is	likely	to	be	mediated	by	universal	membrane	located	cholesterol	transporters	
(e.g.	ABCA1,	ABCG1),	but	also	by	passive	diffusion	and	by	MFG	secretion,	a	specific	secretion	mode	
inherent	to	mammary	epithelial	cells.
•	mRNA	and	protein	expression	of	ABC	cholesterol	 transporters	was	found	in	the	mammary	epithelium	of	
the	blood-milk	barrier	in	lactating	and	nonlactating	mammary	tissue	of	diverse	mammals	including	humans.
•	The	mechanisms	and	regulatory	pathways	mediating	cholesterol	transport	in	the	mammary	gland	and	their	
functional	relevance	in	terms	of	cholesterol	release	into	milk	needs	further	complementary	investigations.
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Abbreviations
ABC ATP-binding cassette
apo-A1 Apolipoprotein-A1
ECD Extracellular domain
HDL High density lipoprotein
LDL Low density lipoprotein
MFG Milk fat globule
NBD Nucleotide binding domain
NPC Niemann-Pick type C
NPC1L1 Niemann-Pick type C1 like 1
TMD Transmembrane domain
VLDL Very low density lipoprotein
8.1 Introduction
8.1.1 Cholesterol in blood and milk
Throughout lactation mammary alveolar epithelial cells synthesize, store, and release specific 
milk constituents, including lipids, into the alveolar milk. Cholesterol found in circulating blood 
originates either from the liver, where acetyl-coenzyme A is used as a precursor for cholesterol 
biosynthesis, or from the dietary uptake in the intestine. The total cholesterol concentration 
measured in the bloodstream consists of fractions bound to different carrier lipoproteins such as 
VLDL, LDL, HDL and chylomicrons, which are synthesized and released into the blood by the 
liver and the intestine.
The total blood serum cholesterol level measured in newborn babies’ blood cord is approx. 70.3 
mg/dl and this level increases with both breast-milk and milk formula intake (Mishkel, 1974). In 
mice, the total blood serum cholesterol level slightly varies from 170 mg/dl at day three of birth to 
200 mg/dl later on (Wang et al., 2011), whereas in cow blood serum cholesterol levels are between 
96.5 and 270.2 mg/dl (Mani et al., 2009). In adult humans, the total blood serum cholesterol level 
varies between 204.6 and 297.2 mg/dl. These values characterize the transition from healthy 
(≤204 mg/dl) to disease conditions. Factors such as weight gain during the pregnancy and the 
number of pregnancies might affect the blood and the milk lipid profiles in healthy women.
The cholesterol requirements of the mammary tissue increase with the onset of lactation. An 
increase of blood and milk cholesterol levels after parturition has been found to be concomitant 
with the up-regulation of cholesterol biosynthetic genes in the liver (Viturro et al., 2009), 
confirming that hepatic cholesterol is required to cover the increasing mammary tissue demand 
due to milk synthesis. Figure 8.1 gives an overview of cholesterol exchanges between the blood, 
the mammary tissue and the milk with its uptake occurring at the basolateral membrane of the 
secretory cells facing the bloodstream, and cholesterol release into milk taking place at the apical 
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side of the secretory cells. The blood-borne carrier lipoproteins such as LDL are the principal 
cholesterol delivery proteins to diverse peripheral extra-hepatic tissues and organs including the 
mammary tissue (Monks et al., 2001). Furthermore, the presence of the LDL receptor in mouse 
mammary tissues, but also an LDL receptor- independent LDL uptake has been demonstrated 
(Monks et al., 2001).
Cholesterol is a component of the milk lipid fraction. The milk lipids exist as globules emulsified 
in the aqueous phase and are the major source of energy for neonates. They form the third 
major milk constituent beside water and lactose (Table 8.1). A wide variability in the milk lipid 
content as well as in the cholesterol content of milk derived products is described across various 
mammalian species (Table 8.2). The milk lipid content increases during feeding and varies over 
the diurnal cycle (Jensen, 1996). Moreover, the milk lipid fraction and its individual components 
such as cholesterol undergo changes during the course of lactation (Jensen, 1996). In humans, 
Figure 8.1. Milk	secretion	pathways	relevant	for	lipids	and	cholesterol	in	mammary	alveolar	epithelial	cells.	
Pathway	I	shows	transporter	proteins	responsible	for	the	direct	movement	of	ions,	water,	glucose,	drugs,	xenobiotics	
and	possibly	lipids/cholesterol	across	both	apical	and	basal	plasma	membranes.	Potentially	involved	proteins	of	
pathway	I	in	the	context	of	lipid	and	cholesterol	transfer	include	scavenger	receptors	at	the	basal	membrane	and	
ABC	transporter	proteins	at	both	the	basal	and	the	apical	side	of	the	plasma	membrane.	Mechanism	II	illustrates	
the	milk	fat	and	lipid	secretion	pathway	with	formation	of	lipid	droplets	that	move	towards	the	apical	membrane	for	
release	as	membrane	bound	milk	fat	globules	(MFG).	Other	mechanisms	such	as	exocytotic	secretion,	vesicular	
transcytosis	and	paracellular	pathways	currently	seem	to	be	less	relevant	for	lipid/cholesterol	transport	and	are	
therefore	not	shown.	ER:	endoplasmic	reticulum,	BM:	basement	membrane,	PC:	plasma	cell,	TJ:	tight	junction,	GJ:	
gap	junction,	DS:	desmosome,	ME:	myoepithelial	cell,	BV:	blood	vessel.
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the milk lipid content is low in the colostrum (~2%) and increases in mature milk (3-4.8%) 
(Table 8.1). In cow milk an inverse milk lipid profile has been shown, where milk lipids were 
higher immediately after parturition (i.e. in colostrum) than later in mature milk (Ontsouka et 
al., 2003). Cholesterol is the predominant component of the milk sterols (95% of total sterols). 
The cholesterol level in human milk is elevated in the colostrum and decreases to approx. 10-20 
mg/dl in mature milk (Table 8.1). These levels are comparable to the cholesterol content in bovine 
mature milk (10-30 mg/dl) corresponding to roughly 10% of blood cholesterol levels (Jensen, 
2002). Milk cholesterol exists also in the form of cholesteryl esters which account for 5-15% of 
total milk cholesterol. This fraction decreases from colostrum to mature milk. In cow milk which 
is preferentially consumed by humans (both infants and adults) the cholesterol content is low 
in colostrum and increases in the mature milk. Furthermore, the blood cholesterol, and more 
generally the blood lipid profile, is influenced by several factors including the diet.
Table 8.1. Constituents	in	human	milk.1
Milk constituent Colostrum Mature milk
Lactose	(g/l) 20-30 67
Oligosaccharides	(g/l) 22-24 12-14
Total	protein	(g/l) 16 9
Total	lipids	(%) 2 3.5
Triglycerides	(%	total	lipids) 97-98 97-98
Cholesterol	(%	total	lipids) 0.7-1.3 0.4-0.5
Cholesterol	(mg/dl) >30 10-20
Phospholipids	(%	total	lipids) 1.1 0.6-0.8
Fatty	acids	(weight	%) 88 88
1	This	table	has	been	adapted	from	Jensen	(1996)	and	Picciano	(2001)	with	permission	from	Elsevier.	In	the	
original	references	additional	information	for	other	milk	constituents	(e.g.	vitamins	and	minerals)	can	be	found.	
Data	are	expressed	as	range	or	single	values.
Table 8.2. Total	lipid	and	cholesterol	levels	in	milk	commonly	consumed	by	humans.1
Milk origin Total lipids (%) Cholesterol (mg per 100 g fat)
Cow 1.38-5.10 239-300
Sheep 5.79-6.45 288±42
Goat 2.75-6.43 341±15
1	Data	are	adapted	from	Jandal	(1996),	Jensen	(2002)	and	Park et al.	(2007)	and	are	published	with	permission	
from	Elsevier.
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8.1.2 Multifaceted health effects of cholesterol
Cholesterol contained in milk and other dairy products is an important source of cholesterol 
in the human diet. Although cholesterol is a ‘minor’ milk lipid component (0.5% of total milk 
lipids), its role in public health, particularly in the context of cardiovascular diseases, is of major 
interest. Cholesterol is an indispensable constituent of biological membranes that is required for 
cell signaling, such as the hedgehog signaling which controls the precise pattern of embryonic 
structure and development (Gofflot et al., 2003). It is also a precursor in the synthesis of multiple 
sterol-based bioactive compounds, e.g. estrogen, testosterone and vitamin D.
Recently, it has been demonstrated that in breastfed babies at six months of age the total blood 
serum cholesterol levels reach up to 194 mg/dl, i.e. almost the same concentration as measured in 
the blood serum of adults. The increase of blood serum cholesterol (including its LDL fraction) 
is more pronounced in breastfed infants already at one month old compared to milk formula fed 
infants (Isomura et al., 2011). It is known that the milk intake by infants in the first six months 
postpartum ranges from 450-1,200 ml/day, and that the average human milk cholesterol content 
is between 100-200 mg/l (Picciano, 2001). Therefore, the daily milk cholesterol intake by infants 
in the early life may vary from 45-240 mg/day. Related to the average infant body weight at 
six months of age, this implies a daily cholesterol intake of 6.5-34 mg cholesterol per kg body 
weight. Assuming an average body weight of 80 kg in adults this would represent the equivalent 
of 0.52 to 2.7 g cholesterol per day. Compared to the recommended daily cholesterol intake of 
approx. 200-400 mg, it is obvious that the cholesterol requirements for adult and newborn/infant 
organisms are markedly different. In contrast to adults, detrimental effects of high cholesterol 
consumption associated with breastfeeding have not been reported yet. Moreover, although a 
consensus is still missing, there are reports describing potentially beneficial effects of exclusive 
breastfeeding. It has been suggested that high total blood serum cholesterol found in breastfed 
infants in early postnatal life might prevent them from the risk of developing cardiovascular 
diseases in older ages (Owen et al., 2005; Rudnicka et al., 2007). On the other hand, it is reported 
that LDL particles may play a role in facilitating the generation of antibodies and that a reduced 
ability to generate antibodies was seen in infants having low blood LDL-cholesterol levels. 
Compared to breastfed infants, those infants with low blood cholesterol were reported to be 
more susceptible to infections and allergic diseases and had increased mortality (Picaud et al., 
2010; Victora et al., 1987). Definitely, in early postnatal life babies need plenty of cholesterol to 
match the cholesterol requirements linked to rapid organ growth, development and maturation, 
especially of the skeletal and the nervous system.
8.2. Mechanisms of cholesterol transport in mammary tissues
Scientific literature describing the transport of cholesterol in lactating and nonlactating human 
mammary tissues is scarce. However, it is likely that the principles governing the transport of 
cholesterol in mammary tissues are not fundamentally different from those known in other 
mammalian peripheral tissues or cells. Accordingly, Figure 8.1 (mechanism I and II) and 
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Figure 8.2 (pathways A-C) illustrate possible pathways of cholesterol transfer from the blood 
side to the apical plasma membrane of mammary alveolar epithelial cells followed by its release 
into milk.
Like other nutrients entering the milk, cholesterol must cross the apical plasma membrane of 
mammary alveolar epithelial cells to enter the alveolar space. Cholesterol taken up at the basal 
side can follow the transcellular pathway towards the apical membrane for its ultimate release into 
Figure 8.2. Overview	of	potential	cholesterol	transfer	mechanisms	at	the	apical	plasma	membrane	of	secretory	
mammary	epithelial	cells	for	release	into	milk.	ABC	transporters	present	at	the	apical	plasma	membrane	mediate	
the	transfer	of	cholesterol	 to	 lipid-poor	apo-A1	(ABCA1)	or	HDL	(ABCG1)	(pathway	A).	Pathway	A	requires	
the	hydrolysis	of	ATP	which,	in	the	case	of	ABCA1	induces	conformational	changes	that	allows	apolipoprotein	
(apo)-A1	binding	and	further	cholesterol	 transfer	and	release.	Alternatively	cholesterol	could	cross	 the	apical	
plasma	membrane	facing	the	alveolar	 lumen	by	diffusion	following	the	concentration	gradient	and	attach	to	
potential	cholesterol	acceptors,	such	as	bovine	serum	albumin	(or	others),	in	the	time	scale	of	hours	(pathway	
B).	The	milk	fat	globule	secretion	mode	(pathway	C)	involves	formation	of	small	lipid	droplets	in	the	endoplasmic	
reticulum	that	then	migrate	towards	the	apical	membrane	as	they	mature.	At	the	apical	region,	lipid	droplets	are	
progressively	surrounded	by	the	plasma	membrane	and	are	then	pinched	off	into	the	milk.
154 Handbook of dietary and nutritional aspects of human breast milk
C. Albrecht, X. Huang and E.C. Ontsouka
milk (Figure 8.1, pathway I). At the apical plasma membrane, different mechanisms are likely to 
operate which involve: (1) active transporters (Figure 8.1, pathway I; Figure 8.2, pathway A); (2) 
passive diffusion processes (Figure 8.2, pathway B); and (3) a specific secretion mode inherent to 
mammary epithelial cells (Figure 8.1, pathway II; Figure 8.2, pathway C). Recent findings in the 
field of cholesterol transport in mammary tissue support the contribution of active cholesterol 
transporters at both the basal and the apical side of mammary alveolar epithelial cells.
8.2.1 Active cholesterol transport
Active cholesterol transport involves the participation of integral plasma membrane proteins, and 
members of the ABC transporter family have been previously implicated in cholesterol trafficking 
across membranes in peripheral tissues (Lee et al., 2002; Stefulj et al., 2009). The prerequisite 
for an involvement of candidate ABC proteins in transcellular cholesterol transport in human 
mammary tissue is their plasma membrane localization (Figure 8.1 and 8.2). In a recent study it 
was demonstrated that ABC transporters – described in more detail thereafter – are important 
candidate proteins for cholesterol transfer in the mammary gland of mammals, including 
humans. The cholesterol transport proteins were found on both the basal and apical side of 
secretory mammary cells by immunostaining (Mani et al., 2010). Furthermore, the proteome of 
the plasma membrane covering the MFG prepared from human and cow milk, demonstrated the 
presence of ABC transporters (Reinhardt and Lippolis, 2006), supporting their potential role in 
cholesterol transfer into milk.
ABC transporters are one of the largest families of integral plasma membrane proteins involved 
in the transport of various substrates across cellular membranes. The transport process requires 
the hydrolysis of ATP, and substrates include ions, sugars, amino acids, vitamins, lipids, and drugs 
as well as larger molecules, such as oligosaccharides, oligopeptides and even high molecular 
weight proteins. ABC transporters consists of intracellular NBD and TMD composed of 6-11 
membrane-spanning α-helices. A functional ABC transporter can be either a complete protein 
with two NBD and two TMD (full transporter) or a dimer of two half transporters (one NBD 
and one TMD each). To date, seven subfamilies (named from A to G) have been identified and 
characterized.
Members of the subfamilies ABCA and ABCG are the most promising candidates regarding 
the transport of cholesterol in the mammary gland because they were identified as cholesterol 
transporters in other mammalian cell types such as gall-bladder epithelial cells (Lee et al., 2002) 
or placental endothelial cells (Stefulj et al., 2009). ABC proteins of the subfamily A differ from 
other ABC transporters by the presence of two large ECDs whose ATP hydrolysis-dependent 
conformational changes are required for cholesterol transport (Nagao et al., 2012). In humans, 
functional defects in ABCA transporter proteins are associated with various diseases such as 
HDL deficiency, pulmonary surfactant deficiency in newborns, or Stargardt disease 1 (Ueda, 
2011). In the next section some of the most promising candidate cholesterol transporters in the 
mammary gland are briefly described.
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ABCA subfamily
ABCA1 plays a major role in the maintenance of cellular cholesterol homeostasis and HDL 
metabolism. ABCA1 is a full transporter of 220 kDa which is localized mainly on the plasma 
membrane and some intracellular compartments like the Golgi network and recycling endosomes 
(Takahashi et al., 2005). The cholesterol transport mediated by ABCA1 necessitates the interaction 
between ABCA1 and lipid-poor apo-A1 which functions as its main cholesterol acceptor. In a 
recent study it has been demonstrated that the ATP hydrolysis at the NBD induces conformational 
changes in the two ECD of ABCA1 that allows apoA-1 binding and subsequent cholesterol efflux 
(Nagao et al., 2012). The interaction of apoA-1 with ABCA1 induces intracellular cascade events 
which involve various signalling proteins (Liu and Tang, 2012). Furthermore, the expression of 
ABCA1 is regulated at both transcriptional and posttranscriptional levels (Ueda, 2011).
ABCA7, another member of the A subfamily, is a full transporter with a highest homology 
to ABCA1. The protein has been identified at the plasma membrane (Linsel-Nitschke et al., 
2005). Although the physiological functions of ABCA7 are still unclear, its role in the process of 
phagocytosis in macrophages has been suggested. ABCA7 null-mice show reduced HDL levels 
and alterations in adipose mass. In vitro studies revealed that ABCA7 promotes the efflux of 
cellular phospholipids onto lipoproteins (Wang et al., 2003).
ABCG subfamily
ABCG1 has structural and expression similarities to ABCA1. It is a half transporter of 75.6 kDa 
that had been implicated in the regulation of macrophage cholesterol and phospholipid transport. 
ABCG1 mediates the transport of cholesterol from cells only to HDL but not to lipid-free apoA-I. 
In addition, it has been demonstrated to play a role in cholesterol movements and trafficking to 
the plasma membrane (Kobayashi et al., 2006; Vaughan and Oram, 2005). This protein may play 
a role in cholesterol redistribution to a cell-surface pool rendering it more accessible to enzymatic 
oxidation and to removal by HDL particles. Similar to ABCA1, the transcriptional regulation of 
ABCG1 expression by nuclear receptors, namely liver X receptors and related partners, modulates 
the cellular lipid and cholesterol efflux, respectively (Velamakanni et al., 2007).
ABCG5 and ABCG8 are also half transporters that must form obligatory heterodimers to become 
functionally active. They are known to be involved in the biliary and intestinal efflux of cholesterol 
and phyto- and shellfish sterols (Kusuhara and Sugiyama, 2007). They are co-ordinately regulated 
through nuclear receptors and other regulatory elements. Mutations in either ABCG5 or ABCG8 
cause sitosterolemia, a rare autosomal recessive disorder characterized by accumulation of both 
plant-derived sterols and animal-derived sterols (cholesterol) in plasma and tissues, leading to 
the development of xanthomas (Velamakanni et al., 2007). The mRNA transcripts of ABCG5 or 
ABCG8 have been identified in the bovine mammary gland (Farke et al., 2006), and therefore 
could be potential cholesterol transporters in this tissue. Their protein expression and functional 
activity in this organ, however, has yet to be elucidated.
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Other cholesterol transport proteins
NPC proteins are integral membrane proteins that are expressed in cytosolic late endosomes and 
lysosomes. They prevent intracellular accumulation of cholesterol derived from the cellular uptake 
of LDL. These proteins exist in two isoforms, NPC1 and NPC2, that bind cholesterol and mediate 
its trafficking and delivery from late endosomes and lysosomes to other cellular compartments 
(Pentchev, 2004). The importance of NPC1 and NPC2 for cholesterol, and more generally lipid 
homeostasis is evidenced in NPC disease where patients with mutations in NPC1 or NPC2, or 
both, face neurodegeneration and die in childhood due to cholesterol and glycosphingolipid 
accumulation in vital organs like brain, liver, and lungs (Vanier and Millat, 2003). NPC1 was 
shown to be expressed and differentially regulated during the pregnancy-lactation cycle in bovine 
mammary tissue (Mani et al., 2009).
NPC1L1 is a transmembrane protein that shares high amino acid homology with NPC1 and has 
a sterol-sensing domain similar to other key genes of cholesterol metabolism (Davies et al., 2000). 
Investigations performed so far showed a differential distribution of NPC1L1 among various 
tissues in humans, rat or mouse. It has been described to play a role in mediating cholesterol 
traffic in the intestine (Altmann et al., 2004) or liver (Tang et al., 2011). However, whether 
this interesting candidate gene is important for cholesterol transport in the mammary gland is 
currently not known.
8.2.2 Diffusion mechanism
In addition to the active transport mechanisms described above, the cholesterol molecule can be 
transferred from cell membranes to an acceptor by diffusion (McLean and Phillips, 1981). The 
diffusion of cholesterol from the phospholipid bilayer to an acceptor, such as HDL particles or 
serum albumin, occurs in a time scale of hours and might be facilitated by plasma membrane 
proteins. Despite the lack of decisive studies in human mammary tissue, cholesterol is likely to 
passively diffuse out of mammary alveolar cells (Figure 8.2, pathway B). In own cholesterol efflux 
studies using primary mammary epithelial cells we observed that after loading of the cells with 
[3H]-cholesterol, the isotope diffuses from the cells into the medium in the absence of cholesterol 
acceptor proteins such as apoA-1 (unpublished data).
8.2.3 Milk fat globule secretion as a potential transport mechanism
The milk lipids are secreted by mammary alveolar epithelial cells as emulsified globules (or lipid 
droplets) surrounded by a protein-rich polar lipid coat called the MFG membrane (Figure 8.1, 
pathway II and Figure 8.2, pathway C). The size of MFG ranges from less than 1 μm to about 
10 μm in diameter (Keenan, 2001; Mather and Keenan, 1998). As shown in Figure 8.1 and 8.2, 
MFG start as small lipid droplets in the ER and migrate towards the apical membrane of the 
secretory mammary cell as they develop and mature. At the apical region, lipid droplets are 
progressively enveloped by the apical plasma membrane and pinched off into the alveolar lumen 
as MFG. The plasma membrane derivative covering MFG contains, among other components, 
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predominantly phospholipids, sphingolipids and sterols. It has been demonstrated that approx. 
80% of the total milk cholesterol is found within the membrane surrounding the MFG membrane 
(Keenan, 2001; Patton and Jensen, 1975). Similarly, the major fraction of phospholipids (approx. 
60% of total milk phospholipids) is also derived from the membrane of MFG. The remaining 
part of both milk cholesterol and phospholipids are found in skim milk (Keenan, 2001; Patton 
and Jensen, 1975). The core of MFG consists essentially of triglycerides (Keenan, 2001), which 
is the predominant milk fat component representing 98% or more of the total milk fat fraction 
depending on the species. Recently, a variation of cholesterol content in MFG of different sizes 
has been described, and it was suggested that the assembly of MFG of different sizes might 
involve specific biosynthetic routes rather than representing a random process (Mesilati-Stahy 
et al., 2011).
It is not clear yet which of the three potential mechanisms described above represents the major 
pathway involved in cholesterol transport in the mammary gland and cholesterol transfer into 
milk. Considering that cholesterol found in milk is predominantly distributed in the membrane 
of MFG, and that MFG secretion is a continuous and a priori energy-independent process, this 
pathway might be crucial for the transfer of cholesterol into milk. Whether the distribution of 
cholesterol in different milk fractions (in milk fat greater than in skim milk) is indicative for 
different secretory routes has, to our knowledge, never been specifically studied. Interestingly, 
ABC transporters including ABCA1 and ABCG1 have also been found in the membrane of 
MFG (Mani et al., 2011). However, whether these proteins may play a functional role in MFG is 
currently not known.
8.3  Comparison of ABC cholesterol transporters in lactating and nonlactating 
mammary tissues
8.3.1 mRNA expression levels of cholesterol transporters
mRNA expression studies of human ABCA1 showed a high expression level in placenta, liver, 
lung, adrenal glands and foetal tissues, and comparably low expression levels, among other tissues, 
in the mammary gland (Langmann et al., 1999). However, if the mammary gland tested in the 
aforementioned study was in the lactating or nonlactating state was not specified. Similar findings 
have also been reported by other investigators showing a lower expression level of ABCA1 mRNA 
in bovine mammary tissues as compared to lung or liver (Farke et al., 2006). The tissue profiling 
of ABCG5 and ABCG8 revealed that both proteins were expressed at relatively low levels in the 
bovine mammary gland as compared to the liver and the digestive tract (Viturro et al., 2006).
Regarding the comparative analysis between lactating and nonlactating mammary tissues only 
very few studies report on this topic (Mani et al., 2009, 2010, 2011). The mRNA expression of 
ABC transporters has not been profiled in healthy lactating and nonlactating human mammary 
tissues probably due to ethical problems with regard to the collection of human breast tissues. In 
a study testing bovine and mouse mammary tissues (Mani et al., 2010), the mRNA expression of 
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ABCA1, ABCG1 and ABCA7 was compared at different physiological and functional stages of 
the mammary gland. Interestingly the mRNA abundance of ABCA1 was significantly higher in 
nonlactating than in lactating murine mammary tissues, whereas the abundance of ABCG1 and 
ABCA7 mRNA transcripts was similar at these two stages. In bovine mammary tissues, however, 
the mRNA abundance of ABCA1, ABCA7 and AGCG1 was signiﬁcantly greater in nonlactating 
than in lactating mammary tissues. Generally, there was a comparable mRNA expression pattern 
between ABCA1 and ABCG1 in murine and bovine mammary tissues, whereas ABCA7 was 
markedly different between the two species. Interestingly, the intracellular cholesterol transporter 
NPC1 showed an inverse expression profile to ABCA1 and ABCG1 during the pregnancy-
lactation cycle in bovine mammary tissues. While ABCA1 was significantly increased during the 
nonlactating stage, the mRNA expression of NPC1 showed a marked suppression in nonlactating 
as compared to lactating mammary tissues (Mani et al., 2009).
8.3.2 Protein localization of cholesterol transporters
ABC transporter protein expression and localization in the mammary epithelium is a prerequisite 
for playing a role in cholesterol exchange between mammary cells and their surroundings. ABCA1 
and ABCA3 expression was identified by immunohistochemistry in the epithelium of normal as 
well as in neoplastic human breast tissues, but also in breast cancer cell lines (Schimanski et al., 
2009). It was reported that ABCA3 and ABCA1 were highly expressed in normal mammary gland 
epithelium. In addition, positive cytoplasmic staining of ABCA1 in breast cancer tissues was 
demonstrated (Schimanski et al., 2009). However, in general, protein data on the expression and 
localization of cholesterol transporters in mammary tissues is still scarce. Parallel to the above 
mentioned mRNA data on ABCA1, ABCA7 and ABCG1 in three different species (Mani et al., 
2010) the authors also compared the protein expression and localization patterns of these proteins 
at different lactational stages (Table 8.3 and Figure 8.3). ABCA1, ABCG1 and ABCA7 proteins 
were stained in the alveolar and ductal epithelium in lactating human mammary tissues (with 
highest intensity for ABCA1 compared with ABCA7 and ABCG1). In nonlactating mammary 
tissue only ABCA1 and ABCA7 were detected by immunohistochemisty (Mani et al., 2010).
On the other hand, ABCG1 was present in mammary adipocytes throughout all stages, whereas 
ABCA1 and ABCA7 were less consistently expressed in this cell type (Table 8.3). This distribution 
pattern suggests that ABCG1 is potentially involved in the regulation of cholesterol storage in 
human mammary adipocytes and/or may play a more prominent role in lactating rather than 
nonlactating mammary tissue.
It was furthermore demonstrated that the ABCA1-, ABCG1- and ABCA7-positive staining 
was completely absent in MEC of nonlactating murine mammary tissue while ABCA1-positive 
mammary adipocytes were detected (Table 8.3, Mani et al., 2010). In lactating murine tissues 
ABCA1, ABCG1, and ABCA7-positive cells were mainly detected in the glandular epithelium 
with diffuse cytoplasmic distribution. In addition, positive staining for ABCA1, ABCG1, and 
ABCA7 was localized in mammary adipocytes of lactating murine mammary tissues (Table 8.3). 
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This localization pattern may suggest that these ABC transporters could be involved in lipid 
secretion and storage by MEC and adipocytes, respectively.
In contrast to the expression pattern in mouse mammary tissues, ABCA1 and ABCG1 -positive 
cells were identified in the mammary epithelium of both nonlactating and lactating bovine 
mammary tissues (Table 8.3 and Figure 8.3, adapted from Mani et al., 2010). These cholesterol 
transporters were localized in the cytoplasm and more frequently in the plasma membrane of 
MEC often with apical accentuation. Furthermore, ABCA1 was localized in endothelial cells. 
Table 8.3. Immunohistological	localization	of	candidate	ABC	transporters	in	various	cell	types	of	lactating	and	
nonlactating	mammary	tissues	(adapted	from	Mani et al.	(2010)	with	permission	from	the	American	Physiological	
Society).1
Species/protein Nonlactating 1 Nonlactating 2 Lactation
MEC AD MEC AD MEC AD
Homo	sapiens
ABCA1 ++ +/– ++ + +++ +
ABCG1 – + – + + +
ABCA7 + – ++ –/+ ++ –/+
Nonlactating Early lactation Mid lactation
MEC AD MEC AD MEC AD
Mus	musculus
ABCA1 – +++ ++ +++ ++ +++
ABCG1 – – + ++ ++ +/–
ABCA7 – – ++ +++ + +
Nonlactating Early lactation Mid lactation
MEC SC MEC SC MEC SC
Bos	taurus
ABCA1 +++ + +++ – +++ +
ABCG1 + – ++ – ++ –
1	Estimated	expression	grade	for	different	cell	types	is	indicated	as	‘–’,	absent;	‘–/+’,	weak	staining	intensity;	
and	‘+’	to	‘+++’,	low-	to	high-staining	intensity.	MEC	=	mammary	secretory	epithelial	cells;	AD	=	mammary	
adipocytes;	SC	=	stromal	cells.	Nonlactating	1	=	ante-menopausal;	Nonlactating	2	=	post-menopausal.
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The presence of ABCA1 and ABCG1 in murine and bovine mammary tissues supports the 
assumption that ABCA1 and ABCG1 play a role in lipid transfer by the mammary epithelium.
The data shown in Figure 8.3 and those published by others (Schimanski et al., 2009) suggest a 
physiological role for ABCA1 in the lactating mammary gland. Furthermore they may suggest 
that ABCG1 could be more important for processes occurring in mammary secretory cells of 
lactating rather than nonlactating mammary tissue. Despite the lack of a functional proof so far, 
the identification and cellular localization of ABCA1 and ABCG1 in human, murine, and bovine 
mammary tissues suggests that these active cholesterol transporters might contribute to lipid 
exchanges between mammary alveolar epithelial cells and their surroundings.
Figure 8.3. Immunohistological	localization	of	the	cholesterol	transporter	ABCA1	in	nonlactating	and	lactating	
mammary	tissues	of	different	species.	Mammary	gland	sections	of	human,	murine	and	bovine	origin	were	stained	
with	a	specific	antibody	against	ABCA1	(brown)	and	counterstained	with	hematoxylin	(blue).	In	human	breast	
samples	NL1	and	NL2	indicate	the	nonlactating	antemenopausal	and	postmenopausal	state,	respectively,	and	L	
the	lactating	state.	In	murine	and	bovine	samples:	NL	=	nonlactating;	EL	=	early	lactation	(mouse:	1-6	days	after	
parturition;	cow:	day	14	of	lactation);	ML	=	midlactation	(mouse:	9-12	days	after	parturition;	cow:	day	88	of	
lactation).	A	=	adipocyte.	Black	arrows	indicate	mammary	epithelial	cells.	Magnification:	×40	(adapted	from	
Mani et al.,	2010	with	permission	from	the	American	Physiological	Society).
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8.4. Summary, conclusions and perspectives
Cholesterol is required for normal functioning of the mammary tissue and is released into milk 
as one of its constituents. Cholesterol is important in MFG formation and is used to substitute 
the removed apical plasma membrane during the exit of MFG. Milk cholesterol is found mainly 
in the membrane of the MFG but is also present in skim milk. Cholesterol intake by babies/
infants who consume exclusively whole breast milk in early postnatal life seems not to have 
negative effects for their immediate and later life in contrast to the well-established detrimental 
cardiovascular consequences associated with high cholesterol intake at older age. In this context, 
further elucidation of mechanisms regulating the transport of cholesterol in mammary tissue is 
of great importance. This might help to design strategies for the optimization of milk cholesterol 
content that should match both elevated cholesterol requirements in infants during the early 
postnatal life and the necessity to prevent cardiovascular disease associated with high cholesterol 
levels in all other milk consumers.
The current scientific evidence suggests that cholesterol transport in the mammary tissue is a 
bi-directional process in terms of exchange at the basal side facing the blood circulation. This 
exchange might involve active transporters such as ABCA1. On the other hand, the transfer of 
cholesterol into milk is mediated probably by both non-energy consuming, ATP-independent 
MFG secretion and ATP-dependent transport mechanisms involving ABC transporters or 
potentially other yet unidentified transporters. The implication of active cholesterol transport 
as one mechanism regulating cholesterol transfer into milk has been predicted by proteomic 
analysis of the membrane of MFG prepared from human milk which identified the presence of 
ABC transporters and associated proteins, such as the cholesterol acceptor apoA-1. The role of 
ABC transporter-mediated cholesterol transfer involving ABCA1 and ABCG1 is supported by 
the localization of the corresponding proteins on the mammary secretory epithelium in lactating 
and nonlactating human mammary tissues, respectively, as well as in surrounding mammary 
adipocytes. Very recently, a cell culture model of mammary epithelial cells grown on monolayers 
in a Transwell® system gave first indications that unstimulated primary mammary epithelial cells 
are able to efflux [3H]-labelled cholesterol to apo-A1 at both the apical and the basal side. Thereby, 
the extent of cholesterol efflux to the basal side was higher than to the apical direction (Ontsouka 
et al., 2013). However, it still remains to be elucidated if (1) mammary alveolar epithelial cells 
transfer cholesterol predominantly via energy-dependent or energy-independent mechanisms; 
(2) whether these processes are dependent of the physiological and functional stage of the 
mammary gland; and (3) how hormones specific for the pregnancy-lactation cycle affect these 
processes.
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